Clinical Trial Update: Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating late surfactant to prevent bronchopulmonary dysplasia in ventilated preterm neonates receiving inhaled nitric oxide has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Respiratory Distress Syndrome of Prematurity

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)
• Late surfactant

Snippet

Sponsor: Roberta Ballard | Conditions: Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction), Bronchopulmonary Dysplasia | Phase 3 | Status: COMPLETED | Results posted: 2016-06-28